Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ronald Peter Erickson Insider Profile
4 Followers
Ronald Peter Erickson, Director at Kalytera Therapeutics, holds 1.20M shares in Kalytera Therapeutics (Ticker: KALTF), holds 200.00K shares in biOasis Technologies (Ticker: TSE:BTI). Most recently, Ronald Peter Erickson Bought ― shares of Kalytera Therapeutics on Sep 19, 2019 for an estimated value of 26.31K.
Ronald Peter Erickson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ronald Peter Erickson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ronald Peter Erickson
Ronald Peter Erickson's Trading History
Kalytera Therapeutics
Sep 19, 2019
Director
Informative Buy
26.31K
$16.80K
biOasis Technologies
Jan 03, 2013
Director
Uninformative Sell
104.00K
C$73.00K
List of latest transactions for each holding click on a transaction to see Ronald Peter Erickson's performance on stock
You May Also Like
Ronald Peter Erickson insider profile FAQ
What is the percentage of profitable transactions made by Ronald Peter Erickson?
The percentage of profitable transactions made by Ronald Peter Erickson is ―.
What is the average return per transaction made by Ronald Peter Erickson?
The average return per transaction made by Ronald Peter Erickson is ―.
What stocks does Ronald Peter Erickson hold?
Ronald Peter Erickson holds: KALTF, TSE:BTI stocks.
What was Ronald Peter Erickson’s latest transaction?
Ronald Peter Erickson latest transaction was an Informative Buy of $26.31K.
What was Ronald Peter Erickson's most profitable transaction?
Ronald Peter Erickson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ronald Peter Erickson's role in Kalytera Therapeutics?
Ronald Peter Erickson's role in Kalytera Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.